Incyte (INCY) Non-Current Deffered Revenue (2010 - 2015)

Incyte (INCY) posted Non-Current Deffered Revenue of $2.9 million for Q3 2015, down 52.84% on a QoQ basis from $6.1 million in Q2 2015, and down 81.76% year-over-year from $15.7 million in Q3 2014.

Incyte (INCY) Non-Current Deffered Revenue (2010 - 2015) Analysis & Trends

Incyte's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $2.9 million for Q3 2015.

  • Quarterly Non-Current Deffered Revenue fell 81.76% year-over-year to $2.9 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $2.9 million (down 81.76% YoY) and the FY2014 annual result came in at $12.5 million, down 50.68% from the prior year.
  • Non-Current Deffered Revenue was $2.9 million for Q3 2015 at Incyte, down from $6.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $154.5 million in Q1 2011 and bottomed at $2.9 million in Q3 2015.
  • A 5-year average of $51.4 million and a median of $31.8 million in 2013 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2013 — Non-Current Deffered Revenue tumbled 33.63% — and 2015, when it tumbled 81.76%.
  • Incyte's Non-Current Deffered Revenue stood at $104.3 million in 2011, then plunged by 63.34% to $38.2 million in 2012, then plunged by 33.63% to $25.4 million in 2013, then slumped by 50.68% to $12.5 million in 2014, then tumbled by 77.07% to $2.9 million in 2015.
  • Business Quant data shows INCY's Non-Current Deffered Revenue at $2.9 million in Q3 2015, $6.1 million in Q2 2015, and $9.3 million in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2015 2.87 Mn
Jun 30, 2015 6.08 Mn
Mar 31, 2015 9.30 Mn
Dec 31, 2014 12.51 Mn
Sep 30, 2014 15.73 Mn
Jun 30, 2014 18.94 Mn
Mar 31, 2014 22.15 Mn
Dec 31, 2013 25.37 Mn
Sep 30, 2013 28.58 Mn
Jun 30, 2013 31.80 Mn
Mar 31, 2013 35.01 Mn
Dec 31, 2012 38.23 Mn
Sep 30, 2012 54.06 Mn
Jun 30, 2012 70.80 Mn
Mar 31, 2012 87.54 Mn
Dec 31, 2011 104.27 Mn
Sep 30, 2011 121.01 Mn
Jun 30, 2011 137.75 Mn
Mar 31, 2011 154.48 Mn
Dec 31, 2010 171.22 Mn